Timo Möttönen - UTU Research Portal

Timo Möttönen

- Docent,
Faculty of Medicine (University of Turku)

timmot@utu.fi

Publications

1 of 2

Reumatologinen hoito TYKS:ssa (2021) Suomen Reumatologinen Yhdistys 75 vuotta 1946-2021 : kollegiaalista yhteistyötä potilaiden hyväksi tieteen avulla Möttönen Timo, Pirilä Laura
(D2 Article in a professional compilation book)
Reumatologista tutkimustyötä TYKS:ssa (2021) Suomen Reumatologinen Yhdistys 75 vuotta 1946-2021 : kollegiaalista yhteistyötä potilaiden hyväksi tieteen avulla Möttönen Timo, Pirilä Laura
(D2 Article in a professional compilation book)
Cervical Spine Involvement is very rare in Patients with Rheumatoid Arthritis Treated actively with Treat to Target Strategy Ten-Year Results of the NEORACo Study (2019)
- Journal of Rheumatology
Tia Sandström, Vappu Rantalaiho, Timo Yli-Kerttula, Hannu Kautiainen, Timo Malmi, Anna Karjalainen, Tea Uusitalo, Heikki Julkunen, Oili Kaipiainen-Seppänen, Leena Paimela, Kari Puolakka, Toini Uutela, Timo Möttönen, Pekka Hannonen, Marjatta Leirisalo-Repo, Leena Laasonen and Markku Kauppi; for the NEO-RACo Study Group
(A1 Refereed original research article in a scientific journal)
Early Targeted Combination Treatment With Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Long-Term Outcomes in Rheumatoid Arthritis: Ten-Year Follow-Up Results of a Randomized Clinical Trial (2019)
- Arthritis care and research
Vappu Rantalaiho, Tia Sandström, Juhani Koski, Pekka Hannonen, Timo Möttönen, Oili Kaipiainen‐Seppänen, Timo Yli‐Kerttula, Markku J. Kauppi, Toini Uutela, Timo Malmi, Heikki Julkunen, Leena Laasonen, Hannu Kautiainen, Marjatta Leirisalo‐Repo; for the NEO‐RACo Study Group
(A1 Refereed original research article in a scientific journal)
Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial (2017)
- PLoS ONE
Vaananen T, Vuolteenaho K, Kautiainen H, Nieminen R, Mottonen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K, Kaipiainen-Seppanen O, Luosujarvi R, Uusitalo T, Uutela T, Leirisalo-Repo M, Moilanen E
(A1 Refereed original research article in a scientific journal)
Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials (2016)
- Clinical and Experimental Rheumatology
Levitsky A, Wick MC, Mottonen T, Leirisalo-Repo M, Laasonen L, Korpela M, van Vollenhoven RF, Rantalaiho V
(A1 Refereed original research article in a scientific journal)
Influence of triple disease modifying anti-rheumatic drug therapy on carotid artery inflammation in drug-naive patients with recent onset of rheumatoid arthritis (2016)
- Rheumatology
Haavisto Matti, Saraste Antti, Pirilä Laura, Hannukainen Jarna C, Kalliokoski Kari K, Kirjavainen Anna, Kemppainen Jukka, Möttönen Timo, Knuuti Juhani, Yli-Kerttula Timo, Roivainen Anne
(A1 Refereed original research article in a scientific journal)
Ovatko biologiset lääkkeet vastanneet odotuksiamme? (2016)
- Duodecim
Möttönen T, Färkkilä M
(D1 Article in a professional journal)
Long-Term Real-Life Experience With Rituximab in Adult Finnish Patients With Rheumatoid Arthritis Refractory or With Contraindication to Anti-Tumor Necrosis Factor Drugs (2015)
- JCR: Journal of Clinical Rheumatology
Valleala H, Korpela M, Hienonen-Kempas T, Immonen K, Lahteenmaki J, Uusitalo T, Komulainen R, Mottonen T, Hannonen P
(A1 Refereed original research article in a scientific journal)
A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland (2014)
- Scandinavian Journal of Rheumatology
KJ Aaltonen, T Sokka, T Möttönen, M Korpela, R Komulainen, T Uusitalo, S Salomaa, T Uutela, H Valleala; for the RAMI study group
(A1 Refereed original research article in a scientific journal)
Failure in Longterm Treatment is Rare in Actively Treated Patients with Rheumatoid Arthritis, But May Be Predicted by High Health Assessment Score at Baseline and by Residual Disease Activity at 3 and 6 Months: The 5-year Followup Results of the Randomized Clinical NEO-RACo Trial (2014)
- Journal of Rheumatology
Rantalaiho V, Kautiainen H, Jarvenpaa S, Korpela M, Malmi T, Hannonen P, Kaipiainen-Seppanen O, Yli-Kerttula T, Mottonen T, Mustila A, Karjalainen A, Paimela L, Uutela T, Leirisalo-Repo M
(A1 Refereed original research article in a scientific journal)
Physicians' adherence to tight control treatment strategy and combination DMARD therapy are additively important for reaching remission and maintaining working ability in early rheumatoid arthritis: a subanalysis of the FIN-RACotrial (2014)
- Annals of the Rheumatic Diseases
Vappu Rantalaiho, Hannu Kautiainen, Markku Korpela, Kari Puolakka, Harri Blåfield, Kirsti Ilva, Pekka Hannonen, Marjatta Leirisalo-Repo, Timo Möttönen; for the FIN-RACo Study Group
(B1 Non-refereed article in a scientific journal)
Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial (2014)
- Annals of the Rheumatic Diseases
Rantalaiho V, Kautiainen H, Korpela M, Hannonen P, Kaipiainen-Seppanen O, Mottonen T, Kauppi M, Karjalainen A, Laiho K, Laasonen L, Hakola M, Peltomaa R, Leirisalo-Repo M; NEO-RACo Study Group
(A1 Refereed original research article in a scientific journal)
Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial (2013)
- Annals of the Rheumatic Diseases
Rantalaiho VM, Kautiainen H, Korpela M, Hannonen PJ, Leirisalo-Repo M, Mottonen T
(B1 Non-refereed article in a scientific journal)
Correlation of F-18-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs (2013)
- European Journal of Nuclear Medicine and Molecular Imaging
Roivainen A, Hautaniemi S, Mottonen T, Nuutila P, Oikonen V, Parkkola R, Pricop L, Ress R, Seneca N, Seppanen M, Yli-Kerttula T
(A1 Refereed original research article in a scientific journal)
Decline in work disability caused by early rheumatoid arthritis – results from a nationwide Finnish register, 2000-8 (2013)
- Annals of the Rheumatic Diseases
Rantalaiho VM, Kautiainen H, Jarvenpaa S, Virta L, Pohjolainen T, Korpela M, Mottonen T, Puolakka K
(A1 Refereed original research article in a scientific journal)
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis – 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study) (2013)
- Annals of the Rheumatic Diseases
Leirisalo-Repo M, Kautiainen H, Laasonen L, Korpela M, Kauppi MJ, Kaipiainen-Seppanen O, Luosujarvi R, Luukkainen R, Karjalainen A, Blafield H, Uutela T, Ilva K, Julkunen HA, Paimela L, Puolakka K, Moilanen E, Hannonen PJ, Mottonen T
(A1 Refereed original research article in a scientific journal)
Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excllent option in early rheumatoid arthritis (2012)
- Clinical and Experimental Rheumatology
Rantalaiho V, Puolakka K, Korpela M, Hannonen P, Möttönen T
(A1 Refereed original research article in a scientific journal)
Reumatologipula kriisiyttää erikoisalan (2012)
- Lääkärilehti
Leirisalo-Repo M, Hannonen P, Möttönen T, Karjalainen A, Korpela M, Kauppi M
(D1 Article in a professional journal)
Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with the FIN-RACo combination and single disease-modifying antirheumatic drug strategies (2011)
- Clinical and Experimental Rheumatology
Mustila A, Korpela M, Haapala A-M, Kautiainen H, Laasonen L, Möttönen T, Leirisalo-Repo M, Ilonen J, Järvenpää S, Luukkainen R, Hannonen P
(A1 Refereed original research article in a scientific journal)